BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Diagnosis
140 results:

  • 1. Molecular Frontiers in Melanoma: Pathogenesis, diagnosis, and Therapeutic Advances.
    Kim HJ; Kim YH
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474231
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and nras mutation characterisation: a single institution experience.
    Moysset I; Castrejon N; Garcia-Herrera A; Castillo P; Marginet M; Teixido C; Podlipnik S; Albero-Gonzalez R; Montironi C; Navarro J; Rovira C; Puig S; Carrera C; Alos L
    Histopathology; 2024 Jun; 84(7):1154-1166. PubMed ID: 38409889
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Melanoma of the central nervous system based on neurocutaneous melanocytosis in childhood: A rare but fatal condition.
    Abele M; Forchhammer S; Eigentler TK; Popescu A; Maschke L; Lohse J; Lehrnbecher T; Behnisch W; Groll AH; Jakob M; Bernbeck B; Brecht IB; Schneider DT
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30859. PubMed ID: 38225622
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Metastatic Undifferentiated Melanoma Mimicking a Primary Bone tumor: A Potential Diagnostic Pitfall.
    Wills A; Dibbern M; Frierson HF; Raghavan SS
    Am J Dermatopathol; 2024 Mar; 46(3):170-172. PubMed ID: 38170737
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PRAME expression in 137 primary cutaneous melanomas and comparison with 38 related metastases.
    Lo Bello G; Pini GM; Giagnacovo M; Patriarca C
    Pathol Res Pract; 2023 Nov; 251():154915. PubMed ID: 37913637
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
    Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
    Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
    Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
    JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular and clinical correlates of HER3 expression highlights its potential role as a therapeutic target in melanoma.
    Shteinman ER; Vergara IA; Rawson RV; Lo SN; Maeda N; Koyama K; da Silva IP; Long GV; Scolyer RA; Wilmott JS; Menzies AM
    Pathology; 2023 Aug; 55(5):629-636. PubMed ID: 37286471
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases].
    Lai YM; Li ZW; Li H; Wu Y; Shi YF; Zhou LX; Lou YT; Cui CL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):262-269. PubMed ID: 37042136
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing.
    Yao X; Zhou H; Duan C; Wu X; Li B; Liu H; Zhang Y
    Front Immunol; 2022; 13():1096494. PubMed ID: 36713456
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An update on genomic aberrations in Spitz naevi and tumours.
    Hagstrom M; Fumero-Velázquez M; Dhillon S; Olivares S; Gerami P
    Pathology; 2023 Mar; 55(2):196-205. PubMed ID: 36631338
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genomics and Epigenomics in the Molecular Biology of Melanoma-A Prerequisite for Biomarkers Studies.
    Zob DL; Augustin I; Caba L; Panzaru MC; Popa S; Popa AD; Florea L; Gorduza EV
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614156
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-III.
    Wang Y; Lian B; Si L; Mao L; Chi Z; Sheng X; Kong Y; Wang X; Bai X; Yan X; Li S; Tang B; Dai J; Zhou L; Wei X; Cui C; Guo J
    Eur J Cancer; 2022 Nov; 175():196-203. PubMed ID: 36137395
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial tumors.
    Kaczorowski M; Chłopek M; Kruczak A; Ryś J; Lasota J; Miettinen M
    Am J Surg Pathol; 2022 Nov; 46(11):1467-1476. PubMed ID: 35973038
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study.
    Luo L; Shen R; Arora A; Orlow I; Busam KJ; Lezcano C; Lee TK; Hernando E; Gorlov I; Amos C; Ernstoff MS; Seshan VE; Cust AE; Wilmott J; Scolyer RA; Mann G; Nagore E; Funchain P; Ko J; Ngo P; Edmiston SN; Conway K; Googe PB; Ollila D; Lee JE; Fang S; Rees JR; Thompson CL; Gerstenblith M; Bosenberg M; Gould Rothberg B; Osman I; Saenger Y; Reynolds AZ; Schwartz M; Boyce T; Holmen S; Brunsgaard E; Bogner P; Kuan PF; Wiggins C; Thomas NE; Begg CB; Berwick M;
    Pigment Cell Melanoma Res; 2022 Nov; 35(6):605-612. PubMed ID: 35876628
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genetics of testicular cancer: a review.
    Martin FC; Conduit C; Loveland KL; Thomas B; Lewin J; Tran B
    Curr Opin Urol; 2022 Sep; 32(5):481-487. PubMed ID: 35855571
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. BRAF and nras prognostic values in conjunctival melanoma: analysis and literature review.
    Valentín-Bravo FJ; Pérez-Rodríguez Á; García-Álvarez C; García-Lagarto E; Saornil-Álvarez MA
    Arq Bras Oftalmol; 2023; 86(5):e20230071. PubMed ID: 35544941
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Metastatic Melanoma to a Neurofibroma.
    Ireland A; Williams B; Rijhumal A; Mesbah Ardakani N
    Am J Dermatopathol; 2022 Sep; 44(9):683-686. PubMed ID: 35475788
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Risk factors for lymphatic and hematogenous metastasis after diagnosis of cutaneous Melanoma in Taiwan.
    Hsu CC; Lee TL; Lin MH; Liao YH; Liau JY; Sheen YS
    J Formos Med Assoc; 2022 Sep; 121(9):1823-1831. PubMed ID: 35292188
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
    Colebatch AJ; Paver EC; Vergara IA; Thompson JF; Long GV; Wilmott JS; Scolyer RA
    Pathology; 2022 Aug; 54(5):533-540. PubMed ID: 35248370
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.